First Header Logo Second Header Logo

Connection

Steven Feldman to Clobetasol

This is a "connection" page, showing publications Steven Feldman has written about Clobetasol.
Connection Strength

5.664
  1. Ramachandran V, Bertus B, Bashyam AM, Feldman SR. Treating Psoriasis With Halobetasol Propionate and Tazarotene Combination: A Review of Phase II and III Clinical Trials. Ann Pharmacother. 2020 09; 54(9):872-878.
    View in: PubMed
    Score: 0.695
  2. Oussedik E, Saleem MD, Feldman SR. A Randomized, Double-Blind, Placebo-Controlled Study of the Vasoconstrictor Potency of Topical 0.25% Desoximetasone Spray: A High to Super High Range of Potency (Class I to Class II) Corticosteroid Formulation. J Drugs Dermatol. 2017 Oct 01; 16(10):972-975.
    View in: PubMed
    Score: 0.588
  3. Taheri A, Moradi Tuchayi S, Alinia H, Orscheln CS, Mansoori P, Feldman SR. Topical clobetasol in conjunction with topical tretinoin is effective in preventing scar formation after superficial partial-thickness burn ulcers of the skin: A retrospective study. J Dermatolog Treat. 2015; 26(4):361-4.
    View in: PubMed
    Score: 0.486
  4. Feldman SR, Winkelman W, Baum E, Preston N. Predicting improvement in signs and symptoms of plaque psoriasis after 1 week of treatment with clobetasol propionate 0.05% spray. J Drugs Dermatol. 2013 Dec; 12(12):1456-60.
    View in: PubMed
    Score: 0.451
  5. Shah A, O'Neill J, Feldman SR. Treatment of moderate-to-severe psoriasis with alefacept for up to one year: a case series. J Drugs Dermatol. 2010 Dec; 9(12):1491-4.
    View in: PubMed
    Score: 0.366
  6. Feldman SR, Koo JY, Johnson LA, Preston NJ. Clobetasol propionate spray 0.05% add-on therapy to a stable regimen of biologic treatment in patients with moderate to very severe plaque psoriasis. Cutis. 2009 Oct; 84(4 Suppl):25-32.
    View in: PubMed
    Score: 0.338
  7. Feldman SR, Yentzer BA. Topical clobetasol propionate in the treatment of psoriasis: a review of newer formulations. Am J Clin Dermatol. 2009; 10(6):397-406.
    View in: PubMed
    Score: 0.321
  8. Feldman SR, Brown KL, Heald P. 'Coral reef' psoriasis: a marker of resistance to topical treatment. J Dermatolog Treat. 2008; 19(5):257-8.
    View in: PubMed
    Score: 0.299
  9. Feldman SR. Effectiveness of clobetasol propionate spray 0.05% added to other stable treatments: add-on therapy in the COBRA trial. Cutis. 2007 Nov; 80(5 Suppl):20-8.
    View in: PubMed
    Score: 0.296
  10. Warino L, Balkrishnan R, Feldman SR. Clobetasol propionate for psoriasis: are ointments really more potent? J Drugs Dermatol. 2006 Jun; 5(6):527-32.
    View in: PubMed
    Score: 0.268
  11. Callender VD, Young CM, Haverstock CL, Carroll CL, Feldman SR. An open label study of clobetasol propionate 0.05% and betamethasone valerate 0.12% foams in the treatment of mild to moderate acne keloidalis. Cutis. 2005 Jun; 75(6):317-21.
    View in: PubMed
    Score: 0.250
  12. Housman TS, Keil KA, Mellen BG, McCarty MA, Fleischer AB, Feldman SR. The use of 0.25% zinc pyrithione spray does not enhance the efficacy of clobetasol propionate 0.05% foam in the treatment of psoriasis. J Am Acad Dermatol. 2003 Jul; 49(1):79-82.
    View in: PubMed
    Score: 0.219
  13. Feldman SR, Housman TS. Patients' vehicle preference for corticosteroid treatments of scalp psoriasis. Am J Clin Dermatol. 2003; 4(4):221-4.
    View in: PubMed
    Score: 0.212
  14. Lebwohl M, Sherer D, Washenik K, Krueger GG, Menter A, Koo J, Feldman SR. A randomized, double-blind, placebo-controlled study of clobetasol propionate 0.05% foam in the treatment of nonscalp psoriasis. Int J Dermatol. 2002 May; 41(5):269-74.
    View in: PubMed
    Score: 0.202
  15. Felix K, Unrue E, Inyang M, Cardwell LA, Oussedik E, Richardson I, Feldman SR. Patients preferences for different corticosteroid vehicles are highly variable. J Dermatolog Treat. 2020 Mar; 31(2):147-151.
    View in: PubMed
    Score: 0.169
  16. Rajabi-Estarabadi A, Hasanzadeh H, Taheri A, Feldman SR, Firooz A. The efficacy of short-term clobetasol lotion in the treatment of scalp psoriasis. J Dermatolog Treat. 2018 Mar; 29(2):111-115.
    View in: PubMed
    Score: 0.145
  17. Mireku K, Huang KE, Narahari S, Davis SA, Feldman SR. Psoriasis treatments by payment type in the US outpatient office setting. J Drugs Dermatol. 2013 Oct; 12(10):1095-7.
    View in: PubMed
    Score: 0.111
  18. Dabade TS, Feldman SR. A consideration when interpreting outpatient data. J Am Acad Dermatol. 2011 Jun; 64(6):1180-1.
    View in: PubMed
    Score: 0.095
  19. Pearce DJ, Stealey KH, Balkrishnan R, Fleischer AB, Feldman SR. Psoriasis treatment in the United States at the end of the 20th century. Int J Dermatol. 2006 Apr; 45(4):370-4.
    View in: PubMed
    Score: 0.066
  20. Lowe N, Feldman SR, Sherer D, Weiss J, Shavin JS, Lin YL, Foley V, Soto P. Clobetasol propionate lotion, an efficient and safe alternative to clobetasol propionate emollient cream in subjects with moderate to severe plaque-type psoriasis. J Dermatolog Treat. 2005 Aug; 16(3):158-64.
    View in: PubMed
    Score: 0.063
  21. Wong JW, Davis SA, Feldman SR, Koo JY. Trends in older adult psoriasis outpatient health care practices in the United States. J Drugs Dermatol. 2012 Aug; 11(8):957-62.
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.